How Stenting Improves Liver Function in Patients with Bile Duct Stones.

To Evaluate the Effect of Stenting on Liver Function in Choledocholithotomy Patients. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080190

Enrollment

Registered

2025-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K803- Calculus of bile duct with cholangitis

Interventions

Intervention1: Stent: Following choledochotomy, patients will receive a biliary stent (Indovasive, India) size 7 -10 Fr 10 cm straight flap into the CBD. The choledochotomy will be closed with continu

Eligibility

Inclusion criteria

Inclusion criteria: Patients in age group of 20 to 60 years Patients of either gender (male/female) Patients with hyperbilirubinaemia in the presence of gallstone disease Patients with controlled hypertension Presence of CBD stones in USG Clinically examined as well as diagnosed patients of Choledocholithiasis Patients willing to sign written consent form

Exclusion criteria

Exclusion criteria: Patients with concomitant diseases like pancreatitis, pancreatic pathology causing jaundice, renal failure, malignancy and evidence of ampullary obstruction Patients with bile duct stenosis Pregnant women

Design outcomes

Primary

Measure	Time frame
Liver Function Test (LFT)Timepoint: 60 post operative day	—

Secondary

Measure	Time frame
CBC RFT Urine (Routine and Microscopy) RBS ECG Chest X-ray PAV USG (whole abdomen) Serum amylase Serum lipase HbsAg HIV 1 and 2 HCV BT/CT PT-INRTimepoint: 60 post operative day	—

Countries

India

Contacts

Public ContactShahid Khan

Ajmal Khan Tibbiya College, Aligarh Muslim University

iqbalaziz@gmail.com9897008768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026